Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Leman

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Frontiers in Molecular Neuroscience|August 30, 2017
Translational Identification of Transcriptional Signatures of Major Depression and Antidepressant ResponseMylène Hervé, Aurélie Bergon, Anne-Marie Le Guisquet, et al.
Molecular Neurobiology|September 4, 2016
Omics to Explore Amyotrophic Lateral Sclerosis Evolution: the Central Role of Arginine and Proline MetabolismFranck Patin, Philippe Corcia, Patrick Vourc'h, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 23, 2016
Combined Metabolomics and Transcriptomics Approaches to Assess the IL-6 Blockade as a Therapeutic of ALS: Deleterious Alteration of Lipid MetabolismFranck Patin, Thomas Baranek, Patrick Vourc'h, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Frontiers in Molecular Neuroscience|August 30, 2017
Translational Identification of Transcriptional Signatures of Major Depression and Antidepressant ResponseMylène Hervé, Aurélie Bergon, Anne-Marie Le Guisquet, et al.
Molecular Neurobiology|September 4, 2016
Omics to Explore Amyotrophic Lateral Sclerosis Evolution: the Central Role of Arginine and Proline MetabolismFranck Patin, Philippe Corcia, Patrick Vourc'h, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 23, 2016
Combined Metabolomics and Transcriptomics Approaches to Assess the IL-6 Blockade as a Therapeutic of ALS: Deleterious Alteration of Lipid MetabolismFranck Patin, Thomas Baranek, Patrick Vourc'h, et al.
Pageof 3